Skip to main content
. 2017 Nov 15;359:j4849. doi: 10.1136/bmj.j4849

Table 1.

Characteristics of randomised controlled trials

Trial n Dropout (%) Follow-up (months) Comorbidities and drugs Mean age (SD) Female (%) Smoke (%) Ethnicity Mean BMI, kg/m2 (SD) Main weight loss interventions Comparisons
Abbenhardt, 2013, USA26 27 439 9.1 12 NR 58.0 (5.0) 100 0 White 30.9 (4.0) Group 1—Diet based on DPP and Look AHEAD (1200-2000 kcal/d, <30% calories from fat, <10% from saturated fat, for 10% weight loss)
Group 2—Diet as above plus exercise programme
Group 3—Control
Group 4—Exercise programme
Abed, 2013, Australia28 150 46.0 15 Atrial fibrillation 60.1 (9.9) 33 5 White 33.3 (3.8) Group 1—Diet
(800-1200 kcal/d for 8 weeks as 2 VLCD sachets and 1 low GI meal; weight maintenance low GI and low fat diet) and exercise advice
Group 2—Control
Ackerman, 2015, USA29 509 15.5 12 Impaired glucose tolerance or impaired fasting glucose 51.0 (12.1) 70.7 NR Mixed 36.8 (8.5) Group 1—Diet based on DPP (low calorie, <25% calories from fat, low saturated fat, for 5-7% weight loss) and exercise advice Group 2—Control
Andrews, 2011, UK30 593 2.4 12 Type 2 diabetes 60.0 (10.1) 35 8 White 31.7 (5.7) Group 1—Diet based on Diabetes UK and Food Standards Agency (<35% calories from fat, <10% from saturated fat, low GI, for 5-10% weight loss)
Group 2—Diet as above and exercise advice
Group 3—Control
Appel, 2003, USA (PREMIER)31-33 810 11.4 18 Above normal blood pressure 50.3 (8.9) 62 5 Mixed 33.1 (5.8) Group 1—Diet (≤30% calories from fat, ≤10% from saturated fat, ≥6.8 kg weight loss) and exercise programme
Group 2—Diet based on DASH (≤25% calories from fat, ≤7% from saturated fat, ≥6.8 kg weight loss) and exercise programme
Group 3—Control
Ard, 2016, USA34 167 11.4 12 Drugs for diabetes, lipids, or blood pressure 70.3 (4.7) 62.2 NR Mixed 33.7 (2.95) Group 1—Diet (28% calories from fat and 500 kcal/d deficit) and exercise programme
Group 2—Diet (28% fat for weight maintenance) and exercise programme
Group 3—Exercise programme
Aveyard, 2016, UK35 1882 24.6 12 NR 56.0 (16.1) 57.2 NR White 34.9 (4.8) Group 1—Diet mainly Slimming World (low fat and low saturated fat) and exercise advice Group 2—Control
Bennett, 2012, USA36 365 14.0 24 Drugs for blood pressure 54.6 (10.9) 69 18 Mixed 37.0 (5.1) Group 1—Diet (low fat and low saturated fat, weight reducing diet) and exercise advice Group 2—Control
Anderson, 2014, UK (BeWEL)37 329 7.3 12 Colorectal adenoma removal 63.6 (6.8) 26 NR White 30.7 (4.2) Group 1—Diet based on British Heart Foundation (600 kcal/d deficit, low fat, low saturated fat, for 7% weight loss) and exercise advice Group 2—Control
Bhopal, 2014, UK16 171 2.3 36 Impaired glucose tolerance or impaired fasting glucose 52.5 (10.3) 54 6 Asian 30.6 (4.8) Group 1—Diet based on the Counterweight programme (500-600 kcal/d deficit, 30% calories from fat, for 5-10% weight loss) and exercise advice Group 2—Control
Blonk, 1994, Netherlands38 60 11.7 24 Type 2 diabetes 58.8* 57 NR White 32.0* Group 1—Diet (500 kcal/d deficit, 30% calories from fat, low saturated fat) and exercise programme Group 2—Control
Burke, 2008, Australia39 241 41.9 40 Drugs for blood pressure 56.2 (7.4) 56 3 White 30.1 (2.7) Group 1—Diet based on DASH (<30% calories from fat, low sat fat, for 5-10% weight loss) and exercise advice Group 2—Control
Daumit, 2013, USA40 291 4.1 18 Psychiatric illness rehabilitation 45.3 (11.3) 50 NR Mixed 36.3 (7.3) Group 1—Diet based on DASH (low fat, low saturated fat, for 4.5 kg weight loss) and exercise programme Group 2—Control
Davis, 1993, USA (TAIM)41 587 31.0 30 Mild hypertension 47.9 (NR) 46 16 Mixed 30.2 (NR) Group 1—Diet (low fat, for 4.5kg or 10% weight loss) and exercise advice Group 2—Control
de Vos, 2014, Netherlands42-44 407 39.3 80 Free of knee osteoarthritis or rheumatic diseases 55.7 (3.2) 100 17.9 White 32.4 (4.3) Group 1—Diet (tailored low fat or low calorie reducing diet) and exercise programme Group 2—Control
de Waard, 1993, Netherlands, Poland45 107 28.6 36 Netherlands, 12 Poland Breast cancer 50-69† 100 NR White 30.2 (NR) Group 1—Diet (1000-1500 kcal/d balanced diet) Group 2—Control
DPP, 2002, USA4 46 47 3234 9.9 34 Impaired glucose tolerance 50.6 (10.7) 67 7 Mixed 34.0 (6.7) Group 1—Diet (low calorie, <25% calories from fat, low saturated fat, for 7% weight loss) and exercise programme Group 2—Control and metformin placebo
Finnish DPS, 2009, Finland3 48 49 523 16.4 138 Impaired glucose tolerance 55.2 (7.2) 67 7 White 31.3 (4.5) Group 1—Diet (<30% calories from fat, <10% from saturated fat, for ≥5% weight loss) and exercise programme Group 2—Control
Fitzgibbon, 2010, USA50 213 10.8 18 NR 46.0 (8.4) 100 NR Black 39.2 (5.7) Group 1—Diet (low calorie, low fat, for 7% weight loss) and exercise programme Group 2—Control
Gabriel, 2011, USA51 508 10.2 48 Postmenopausal, some on hormone replacement therapy 57.0 (2.9) 100 6 White 30.8 (3.8) Group 1—Diet (<17% calories from fat, <4% from saturated fat, 1300-1500 kcal/d) and exercise advice Group 2—Control
Goodwin, 2014, Canada, USA52 338 12.7 24 Breast cancer, letrozole therapy 61.0 (7.2) 100 7 White 31.3 (5.2) Group 1—Diet based on DPP (20% calories from fat, 500-1000 kcal/d deficit) and exercise advice Group 2—Control
Greaves, 2015, UK53 108 11.1 12 High cardiovascular risk 65.1 (7.0) 30.6 NR White 32.7 (3.1) Group 1—Diet (low fat, low sat fat diet, for ≥5% weight loss) and exercise advice Group 2—Control
Green, 2015, USA54 200 18.0 24 Antipsychotic drugs 47.2 (10.6) 72 33 White 38.3 (8.3) Group 1—Diet based on DASH (≤30% calories from fat, ≤10% from saturated fat, for 4.5-6.8 kg weight loss) and exercise programme Group 2—Control
Heller, 1988, UK55 87 13.8 12 Diabetes 56.5 (7.7) 52 NR White 31.6 (3.3) Group 1—Diet (low sugar, high fibre for weight loss) Group 2—Control
Heshka, 2003, USA56 423 27.0 24 NR 44.5 (10.0) 85 9 White 33.7 (3.6) Group 1—Diet (Weight Watchers for weight loss of 0.9 kg/w) and exercise advice Group 2—Control
Horie, 2016, Brazil57 80 6.3 12 Mild cognitive impairment 68.1 (4.9) 83.8 1.3 Mixed 35.5 (4.4) Group 1—Diet (<30% calories from fat, 500 kcal/d deficit) and exercise advice Group 2—Control
Hunt, 2014, UK (FFIT)58 748 17.7 12 NR 47.1 (8.0) 0 NR White 35.3 (4.9) Group 1—Diet (low fat, 600 kcal/d deficit, healthy eating) and exercise programme Group 2—Control
Hydrie, 2012, Pakistan59 317 13.6 18 Impaired glucose tolerance 43.6 (9.9) 25 NR Asian 27.0 (5.0) Group 1—Diet (<30% calories from fat, for ≥5% weight loss) and exercise programme Group 2—Control
Katula, 2013, USA60 301 13.3 24 Impaired fasting glucose 57.9 (9.5) 58 5 Mixed 32.7 (4.0) Group 1—Diet based on DPP (low calorie, 25-30% fat, 7% saturated fat, 1200-1800 kcal/d, for 5-7% weight loss) and exercise advice Group 2—Control
Li Da Qing, 2014, China17 61-63 577 (33 clinics) 8.1 72 Impaired glucose tolerance 45.0 (9.1) 47 41 Asian 25.8 (3.8) Group 1—Diet (BMI <25, 25-30 kcal/kg, 25-30% calories from fat; BMI ≥25 reduce calories to lose 0.5-1 kg/month, until BMI=23).
Group 2—Diet as above and exercise advice
Group 3—Control
Group 4—Exercise advice
Logue, 2005, USA64 665 34.6 24 NR 52.3 (NR) 69 NR Mixed 34.2 (NR) Group 1—Diet based on DGA (low calorie, low fat, low saturated fat, portion control) and exercise advice Group 2—Control
Look AHEAD, 2013, USA65 66 5145 3.7 115 Type 2 diabetes 58.8 (6.9) 60 4 Mixed 36.0 (5.9) Group 1—Diet (1200-1800 kcal/d, <30% calories from fat, <10% from saturated fat, for 7% weight loss, meal replacements) and exercise programme Group 2—Control
Ma, 2013, USA67 241 34.4 24 Impaired fasting glucose or metabolic syndrome 52.9 (10.6) 47 NR White 32.0 (5.4) Group 1—Diet based on DPP (500-1000 kcal/d deficit, 25% calories from fat, for 7% weight loss) and exercise programme
Group 2—Self directed diet and exercise as above
Group 3—Control
Mengham, 1999, UK68 75 1.3 12 Diabetes 60.6 (12.5) 45 NR White 31.6 (4.6) Group 1—Diet based on British Dietetic Association recommendations (low fat) Group 2—Control
Messier, 2013, USA69 454 12.1 18 Knee osteoarthritis 66 (NR)6 72 NR White 33.6 (3.7) Group 1—Diet based on DGA (800-1000 kcal/d deficit, meal replacements ≤2/day, <30% calories from fat)
Group 2—Diet as above and exercise programme
Group 3—Exercise programme
Oldroyd, 2006, UK70 78 30.8 24 Impaired glucose tolerance 57.9 (NR) 44 NR White 30.2 (5.3) Group 1—Diet (aim for BMI <25, ≤30% calories from fat, PUFA/SFA ratio ≥1.0) and exercise programme Group 2—Control
O’Neil, 2016, USA71 563 14.0 12 Type 2 diabetes 55.1 (19.1) 71.0 NR Mixed 37.1 (5.7) Group 1—Diet (Weight Watchers, hypoenergetic healthy eating) and exercise advice Group 2—Control
Patrick, 2011, USA72 441 29.9 12 NR 43.9 (8.0) 0 NR White 34.3 (4.1) Group 1—Diet based on DGA (saturated fat ≤20 g/day) and exercise advice Group 2—Control
Penn, 2009, UK73 102 48.0 37 Impaired glucose tolerance 57.1 (NR) 60 NR White 33.8 (5.1) Group 1—Diet (reduced saturated fat and <30% calories from fat until BMI <25) and exercise advice Group 2—Control
Perri, 2014, USA74 612 19.6 24 NR 52.3 (11.5) 78 NR White 36.3 (4.0) Groups 1-3—Diet based on DPP (1200-1800 kcal/d, low fat) and exercise advice. Three groups received different intensities of both diet and exercise interventions Group 4—Control
Ramachandran, 2006, India75 531 5.5 30 Impaired glucose tolerance 45.9 (5.7) 21 22 Asian 25.8 (3.5) Group 1—Diet (low calorie, low fat) and exercise advice
Group 2—Diet as above and exercise advice and metformin
Group 3—Control
Group 4—Metformin
Rejeski, 2011, USA (CLIP)76 288 13.5 18 Recent cardiovascular disease, metabolic syndrome, or mobility limitation 67.1 (4.8) 67 NR White 32.8 (3.8) Group 1—Diet based on DGA (1200-1800 kcal/d, low fat, for 7-10% weight loss) and exercise programme Group 2—Control
Group 3—Exercise programme
Rock, 2015, USA77 78 698 15.9 24 Breast cancer 56 (NR)9 100 3.45 White 31.5 (4.7) Group 1—Diet (500-1000 kcal/d deficit, low energy density, for 7% weight loss) and exercise advice Group 2—Control
Ross, 2012, Canada (PROACTIVE)79 490 19.2 24 NR 51.8 (11.4) 70 NR White 32.3 (4.2) Group 1—Diet (balanced Mediterranean type diet for weight loss, 5-10% reduction in waist circumference) and exercise advice Group 2—Control
Saito, 2011, Japan80 641 9.2 36 Impaired fasting glucose 49.0* 29 27 Asian 27.0 (2.6) Group 1—Diet (low calorie, 20-25% calories from fat, for 5% weight loss) and exercise advice Group 2—Control
Shea, 2010, USA (ADAPT)81 82 318 20.8 96 Knee osteoarthritis 68.7 (5.4) 72 NR Mixed 34.2 (5.5) Group 1—Diet based on TONE based (500 kcal/d deficit, fat and portion control, for 5% weight loss)
Group 2—Diet as above and exercise programme
Group 3—Control
Group 4—Exercise programme
Shea, 2011, USA (TONE) 83-85 585 <20 152 Drugs for blood pressure 66.0 (4.3) 53 5 Mixed 31.2 (2.3) Group 1—Diet (low calorie, low fat, for ≥4.5 kg weight loss) and exercise programme
Group 2—Diet (low calorie, low fat, for ≥4.5 kg weight loss), exercise programme, and sodium restriction
Group 3—Control
Group 4—Sodium restriction
TOHP II, 2007, USA86 87 2382 23.0 144 High normal diastolic blood pressure 43.6 (6.1) 34 9 Mixed 30.9 (3.1) Group 1—Diet (low calorie, low fat, for ≥4.5 kg weight loss) and exercise programme
Group 2—Diet (low calorie, low fat, for ≥4.5 kg weight loss), exercise programme, for sodium restriction
Group 3—Control
Group 4—Sodium restriction
Toobert, 2000, USA88 28 10.7 24 Coronary heart disease 63.6 (10.4) 100 7 White 32.0 (4.8) Group 1—Diet based on Ornish (vegetarian diet, <10% calories from fat) and exercise programme Group 2—Control
Uusitupa, 1993, Finland89-91 90 8.9 24 Type 2 diabetes 53.2 (6.6) 43 17 White 33.5 (5.1) Group 1—Diet (≤30% calories from fat, ≤10% from saturated fat) and exercise advice Group 2—Control
Villareal, 2011, USA92 107 13.1 12 Frailty 69.7 (4.0) 63 NR White 37.2 (5.0) Group 1—Diet (balanced diet, 500-750 kcal/d deficit, for 10% weight loss)
Group 2—Diet as above and exercise programme
Group 3—Control
Group 4—Exercise programme
Wadden, 2011, USA93 390 13.8 24 Metabolic syndrome 51.5 (11.5) 80 NR Mixed 38.5 (4.7) Group 1—Diet based on DPP (1200-1800 kcal/d, 20-35% calories from fat) and exercise advice (brief counselling)
Group 2—Diet based on DPP (1200-1800 kcal/d, 20-35% calories from fat; meal replacements, orlistat or sibutramine if required) and exercise advice (enhanced counselling)
Group 3—Control
Wing, 2010, USA (PRIDE) 94 95 338 14.5 18 Urinary incontinence 52.7 (10.3) 100 5 Mixed 36.3 (5.3) Group 1—Diet based on DPP and Look AHEAD (1200-1800 kcal/d, <30% calories from fat, for 7-9% weight loss, SlimFast vouchers) and exercise advice Group 2—Control
Yardley, 2014, UK96 179 31.3 12 NR 51.2 (13.1) 64 NR White 35.7 (5.5) Group 1—Diet ( self selected from: 600k cal/d deficit by reducing portions; or traffic light system; or low carbohydrate diet ≤50 g/d with traffic light system) and exercise advice (web based)
Group 2—Diet as above and exercise advice (basic nurse support)
Group 3—Diet as above and exercise advice (regular nurse support)
Group 4—Control

1 kcal=4.18 kJ

*Median

†Range

ADAPT=arthritis, diet, and activity promotion trial; CLIP=community level interventions for pre-eclampsia; DASH=dietary approaches to stop hypertension; DGA=dietary guidelines for Americans; DPP=diabetes prevention program; DPS=diabetes prevention study; FFIT=football fans in training; GI=glycaemic index; Look AHEAD=look action for health in diabetes; NR=not reported; PRIDE=program to reduce incontinence by diet and exercise; PUFA/SFA=polyunsaturated fatty acids/saturated fatty acids; SD=standard deviation; TAIM=trial of antihypertensive interventions and management; TONE=trial of nonpharmacologic intervention in the elderly; TOHP=trials of hypertension prevention; VLCD=very low calorie diet.